Drug Study
Ampicillin Brand Name: Ampicin Classification: Antibiotic Dosage: 200 mg Route: TIV Frequency: q 6°  Action Bactericidal  action againts sensitive organisms; inhibits synthesis of bacteria cell wall, causing cell death Indication Treatment of soft tissue, respiratory tract infections, septicemia, menigitis and gonococcal infections caused by susceptible microorganisms  Contraindication Contraindicated with  allergies to penicillins,  cephalosporins, or  other allergens Use cautiously with renal disorders    Adverse Reaction CNS: headache, hallucinations seizures CV: CHF GI: nausea and vomiting, abdominal pain, bloody diarrhea GU: nephritis Hematologic: anemia, leukopenia, neutropenia, prolonged bleeding time Hypersensitivity: rash, fever, wheezing Local: pain, phlebitis, thrombosis at injection site(parenteral)   Nursing Consideration Before giving, ask the patient about any allergic reaction to penicillin. Use initial dilution within one hour. Follow manufacturers direction for stability data when ampicillin is furthered diluted for IV infusion. Give IV intermittently to prevent vein irritation. Change site every 48 hrs. Don’t give IV unless prescribed and infection is severe. give ampicillin at least one hour before bacteriostatic antibiotics Do not give with fruit juice or softdrinks. Tell to the parent of the patient to call the doctor if rash, fever , or chills develop

    


note presence of associated signs (diaphoresis. uticaria  Nursing Consideration Advice parents or caregivers to check concentrations of liquid preparations.Drug Study Paracetamol Brand Name: Biogesic Classification: Antipyretic Dosage: 120 mg/mL Route: PO Frequency: 1 tsp. Effect of medication is reduce if full pain response recurs prior to next dose. and malaise) Assess for clinical improvement and relief of pain. duration of pain. hepatoxicity. fever. Errors have resulted in serious liver damage. fever. skin erythema. all of which increase risk of hepatoxicity      Adverse Reaction Hema: hemolytic anemia. Acts centrally on the hypothalamic heat regulating center. leucopenia. Therapuetic effect: results in antipyresis produces analgesic effect. failure (high dose/chronic use) Derm: rash.  liver disease. location. Assess onset. block pain impulses through peripheral action. q 6°  Action Appears to inhibit prostaglandin synthesis in the CNS and. type.  Contraindication Active alcoholism. Assess fever. to a lesser extent. tachycardia. neutropenia. pancytopenia Hepa: jaundice Metabolic: hypoG GI: hepatic failure.(overdose) GU: renal. producing peripheral vasodition (heat loss. or viral hepatitis.  Indication Relief of mild to moderate pain.    58 . diaphoresis).

regional enteritis. visual adaptation to darkness. malaise. Therapeutic effect: essential for normal function of retina.000 international units. it should be omitted        59 . irritability. fever. testicular and ovarian function. embryonic development.000 IU Route: PO Frequency: SD   Action May act as cofactor  in biochemical reaction.  Adverse Reaction CNS: Vertigo. pancreatic disease. preserve integrity of ephetilial cells. extreme dietary inadequacy. bone growth.partial gastrectomy. ciliac disease. Excessive doses of vitamin A should be avoided in pregnancy because of potential tetratogenic effect. hepatic cirrhosis. Monitor therapeutic serum Vitamin A levels(80-300 units/mL) Oral preparation are not induicated for Vitamin A deficiency in those with malabsorption syndrome Caution patient not to take more than the prescribed amount. lethargy.Drug Study Vitamin A Brand Name: Retinol Classification: Nutritional suplemment Dosage: 20. sprue colitis. cystic fibrosis) Contraindication  Hypersensitivity. headache GI: weight loss Metabolic: hyperglycemia Ocular: visual changes Miscellaneous: hypervitaminosis  Nursing Consideration Closely supervise for overdosage symptoms during prolonged daily administrations over 25. Indication Treatment of vitamin A dificiency (biliary tract.

GI obstruction Local: tissue sloughing. hyperkalemia. local necrosis. Monitor ECG and serum electrolyte levels during therapy. Monitor renal function. contrucion of cardiac skeletal. Drug Study Potassium Chloride Brand Name: Kalium Classification: Electrolyte Dosage: 2.X. severe burns. Monitor IV injection sites regularly for necrosis. vomiting. local phlebitis  Nursing Considerations Never IV push give slowly as dilute solution: potentially fatal hyperkalemia may result from too-rapid infusion Make sure powders are completely dissolved before administering.        60 . do not add potassium to an IV bottle in the hanging position.6 mEq/L Incorporaed: D5 IMB 500cc Route: TIV Action Necessary for multiple cellular metabolic processes.  Indication For use as an electrolyte replenisher Treatment of hypokalemia. Abdominal discomfort with distention. digitals toxicity. Required for nerve impulse conduction. postoperative oligiria. tissues sloughing ad phlebitis. Nausea. Agitate preffered IV solution to prevent “layering” of potassium. maintains normal renal function. severe renal impairment. smooth muscle. Contraindication  Concurrent use of potassium-sparing diuretics.   Adverse Reaction Dermatologic: Rash GI: Diarrhea. Primary action is intracellular. shock with dehydration or hemolytic reaction. heat cramps.

61 .